EPAS1 and leukemia: Of note, in the AML1-ETO mouse model it was reported that genetic deletion of the HIF1α gene resulted in compensatory expression of HIF2α (111), which led the authors to suggest that HIF2α upregulation may lead to increased leukemia aggressiveness, at least in some genetic backgrounds of AML.